JP7486015B2 - Component for genetic testing container, and genetic testing container - Google Patents
Component for genetic testing container, and genetic testing container Download PDFInfo
- Publication number
- JP7486015B2 JP7486015B2 JP2019187669A JP2019187669A JP7486015B2 JP 7486015 B2 JP7486015 B2 JP 7486015B2 JP 2019187669 A JP2019187669 A JP 2019187669A JP 2019187669 A JP2019187669 A JP 2019187669A JP 7486015 B2 JP7486015 B2 JP 7486015B2
- Authority
- JP
- Japan
- Prior art keywords
- genetic testing
- testing container
- nucleic acid
- mixture
- container
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000012360 testing method Methods 0.000 title claims description 68
- 230000002068 genetic effect Effects 0.000 title claims description 64
- 239000000203 mixture Substances 0.000 claims description 34
- 239000003153 chemical reaction reagent Substances 0.000 claims description 30
- 108090000790 Enzymes Proteins 0.000 claims description 20
- 102000004190 Enzymes Human genes 0.000 claims description 20
- 239000000758 substrate Substances 0.000 claims description 20
- 108020004707 nucleic acids Proteins 0.000 claims description 19
- 150000007523 nucleic acids Chemical class 0.000 claims description 19
- 102000039446 nucleic acids Human genes 0.000 claims description 19
- 230000004544 DNA amplification Effects 0.000 claims description 18
- 239000011342 resin composition Substances 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 13
- 238000001668 nucleic acid synthesis Methods 0.000 claims description 13
- 239000007853 buffer solution Substances 0.000 claims description 8
- 230000002194 synthesizing effect Effects 0.000 claims description 6
- 229910019142 PO4 Inorganic materials 0.000 claims description 4
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 claims description 4
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 claims description 4
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 claims description 4
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 claims description 4
- 235000021317 phosphate Nutrition 0.000 claims description 4
- 150000003013 phosphoric acid derivatives Chemical class 0.000 claims description 4
- AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 claims description 2
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 claims description 2
- 239000000243 solution Substances 0.000 description 29
- 238000006243 chemical reaction Methods 0.000 description 26
- 229920005989 resin Polymers 0.000 description 19
- 239000011347 resin Substances 0.000 description 19
- 238000002360 preparation method Methods 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- -1 polyethylene Polymers 0.000 description 6
- 239000000872 buffer Substances 0.000 description 5
- 229920002725 thermoplastic elastomer Polymers 0.000 description 5
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 4
- 239000008223 sterile water Substances 0.000 description 4
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 3
- 239000005977 Ethylene Substances 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 238000007429 general method Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000000465 moulding Methods 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- VSKJLJHPAFKHBX-UHFFFAOYSA-N 2-methylbuta-1,3-diene;styrene Chemical compound CC(=C)C=C.C=CC1=CC=CC=C1.C=CC1=CC=CC=C1 VSKJLJHPAFKHBX-UHFFFAOYSA-N 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- FACXGONDLDSNOE-UHFFFAOYSA-N buta-1,3-diene;styrene Chemical compound C=CC=C.C=CC1=CC=CC=C1.C=CC1=CC=CC=C1 FACXGONDLDSNOE-UHFFFAOYSA-N 0.000 description 2
- 239000011363 dried mixture Substances 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 239000000806 elastomer Substances 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 239000003505 polymerization initiator Substances 0.000 description 2
- 229920005672 polyolefin resin Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 239000013615 primer Substances 0.000 description 2
- 239000002987 primer (paints) Substances 0.000 description 2
- 229920000468 styrene butadiene styrene block copolymer Polymers 0.000 description 2
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- YVXDRFYHWWPSOA-BQYQJAHWSA-N 1-methyl-4-[(e)-2-phenylethenyl]pyridin-1-ium Chemical compound C1=C[N+](C)=CC=C1\C=C\C1=CC=CC=C1 YVXDRFYHWWPSOA-BQYQJAHWSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 1
- 239000004709 Chlorinated polyethylene Substances 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 241000186781 Listeria Species 0.000 description 1
- 241000158509 Listeria monocytogenes FSL F6-684 Species 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000000071 blow moulding Methods 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000005513 chalcones Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 239000012954 diazonium Substances 0.000 description 1
- 150000001989 diazonium salts Chemical class 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229920006242 ethylene acrylic acid copolymer Polymers 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 229920000554 ionomer Polymers 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 229920013716 polyethylene resin Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- DQFBYFPFKXHELB-VAWYXSNFSA-N trans-chalcone Chemical compound C=1C=CC=CC=1C(=O)\C=C\C1=CC=CC=C1 DQFBYFPFKXHELB-VAWYXSNFSA-N 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Landscapes
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Description
本発明は、遺伝子検査技術に関し、特に核酸を増幅するための反応液調製工程の簡略化に関する。 The present invention relates to genetic testing technology, and in particular to the simplification of the reaction solution preparation process for amplifying nucleic acids.
従来、遺伝子検査などにおいて、核酸を増幅するための反応液を調製する場合、一般に、ユーザがチューブなどの遺伝子検査容器を用いて、数μLから数十μL程度の微量な溶液を複数回調製する必要があった。
具体的には、例えばPCR用反応液を調製する場合、図2に示すように、緩衝液、基質(核酸合成基質)、プライマー、及び酵素(核酸合成酵素)の4種類の試薬をチューブに注入して調製する工程を行う必要があった。
すなわち、ユーザは、1サンプルあたり4回の調製を行った後、検査対象の核酸(以下、対象核酸と称する場合がある。)をチューブに注入する必要があった。このような微量な溶液の調製は非常に煩雑であるため、簡略化できれば有益である。
Conventionally, when preparing a reaction solution for amplifying nucleic acid in genetic testing, the user generally had to prepare minute amounts of solution (a few μL to a few tens of μL) multiple times using a genetic testing container such as a tube.
Specifically, for example, when preparing a reaction solution for PCR, a process was required in which four types of reagents, namely a buffer solution, a substrate (nucleic acid synthesis substrate), a primer, and an enzyme (nucleic acid synthesis enzyme), were injected into a tube to prepare the reaction solution, as shown in FIG.
In other words, the user had to perform preparation four times per sample and then inject the nucleic acid to be tested (hereinafter, sometimes referred to as the target nucleic acid) into the tube. Since preparation of such a small amount of solution is very complicated, it would be beneficial if the process could be simplified.
ここで、このような問題を解消する方法として、各種試薬を混合し、凍結乾燥させて混合物を作成し、これを用いることが考えられる(特許文献1参照)。
すなわち、緩衝液、基質、プライマー、及び酵素の凍結乾燥による混合物を、メーカが予め内部に固定したチューブを提供すれば、ユーザは、4回の調製を省略することが可能になる。
One possible method for solving such problems is to mix various reagents and freeze-dry them to prepare a mixture, which can then be used (see Patent Document 1).
That is, if the manufacturer provides a tube with a freeze-dried mixture of buffer, substrate, primer, and enzyme pre-fixed inside, the user can eliminate four preparation steps.
しかしながら、このような凍結乾燥法では、真空乾燥機などの機器を準備する必要がある。また、真空乾燥を行う場合には、水分により酵素が不安定になったり失活したりすることを防ぐために、低湿度環境下で行うことが必須であり、特別な施設が必要であった。 However, this type of freeze-drying method requires the preparation of equipment such as a vacuum dryer. In addition, when performing vacuum drying, it is essential to carry out the process in a low-humidity environment to prevent the enzymes from becoming unstable or inactivated due to moisture, and special facilities are required.
そこで、本発明者は、特別な機器や施設を用いることなく、核酸を増幅するための反応液の調製工程を簡略化可能な手法を鋭意研究して、各種試薬を樹脂組成物と共に混合し、この混合物を固定した遺伝子検査容器用部材及び遺伝子検査容器を作製することにより、該調製工程を簡略化することに成功して、本発明を完成させた。 The inventors therefore conducted extensive research into a method that can simplify the preparation process of a reaction solution for amplifying nucleic acids without using special equipment or facilities, and succeeded in simplifying the preparation process by mixing various reagents with a resin composition and producing a genetic testing container component and a genetic testing container in which this mixture is fixed, thereby completing the present invention.
すなわち、本発明は、特別な機器や施設を必要とすることなく、DNAを増幅するための反応液の調製工程を簡略化可能な遺伝子検査容器用部材、及び遺伝子検査容器の提供を目的とする。 In other words, the present invention aims to provide a component for a genetic testing container and a genetic testing container that can simplify the process of preparing a reaction solution for amplifying DNA without requiring special equipment or facilities.
上記目的を達成するため、本発明の遺伝子検査容器用部材は、少なくとも核酸合成酵素を含む一又は複数の遺伝子増幅用試薬と、樹脂組成物とを含む混合物が基板上の少なくとも一部に塗布されてなる構成としてある。 To achieve the above object, the genetic testing container member of the present invention is configured such that a mixture containing one or more gene amplification reagents, including at least a nucleic acid synthesizing enzyme, and a resin composition is applied to at least a portion of a substrate.
また、本発明の遺伝子検査容器用部材を、前記樹脂組成物が感光性樹脂組成物であり、前記混合物の表面が紫外線照射により硬化されてなる構成とすることが好ましい。 In addition, it is preferable that the genetic testing container member of the present invention is configured such that the resin composition is a photosensitive resin composition and the surface of the mixture is cured by irradiation with ultraviolet light.
また、本発明の遺伝子検査容器用部材を、前記遺伝子増幅用試薬が、核酸合成酵素と共に、核酸合成基質と、プライマーと、緩衝液とからなる群より選択される少なくともいずれかを含む構成とすることが好ましい。 In addition, it is preferable that the gene amplification reagent of the genetic testing container member of the present invention contains at least one selected from the group consisting of a nucleic acid synthesis substrate, a primer, and a buffer solution together with a nucleic acid synthesis enzyme.
また、本発明の遺伝子検査容器用部材を、前記遺伝子検査がPCR法による増幅産物を用いて検査するものである構成とすることが好ましい。 It is also preferable that the genetic testing container member of the present invention is configured so that the genetic testing is performed using an amplified product obtained by the PCR method.
さらに、本発明の遺伝子検査容器は、上記のいずれかに記載の遺伝子検査容器用部材を用いて形成され、前記混合物が当該容器内に固定された構成としてある。 Furthermore, the genetic testing container of the present invention is formed using any of the genetic testing container members described above, and the mixture is fixed within the container.
本発明によれば、特別な機器や施設を必要とすることなく、核酸を増幅するための反応液の調製工程を簡略化できる遺伝子検査容器用部材、及び遺伝子検査容器の提供が可能となる。 The present invention makes it possible to provide a component for a genetic testing container and a genetic testing container that can simplify the process of preparing a reaction solution for amplifying nucleic acids without requiring special equipment or facilities.
以下、本発明の遺伝子検査容器用部材、及び遺伝子検査容器の一実施形態について詳細に説明する。ただし、本発明は、以下の実施形態及び後述する実施例の具体的な内容に限定されるものではない。
本実施形態の遺伝子検査容器用部材は、少なくとも核酸合成酵素を含む一又は複数の遺伝子増幅用試薬と、樹脂組成物とを含む混合物が基板上の少なくとも一部に塗布されてなることを特徴とする。
Hereinafter, an embodiment of the member for a genetic testing container and the genetic testing container of the present invention will be described in detail. However, the present invention is not limited to the specific contents of the following embodiment and the examples described later.
The member for a genetic testing container of this embodiment is characterized in that a mixture containing one or more gene amplification reagents containing at least a nucleic acid synthesizing enzyme and a resin composition is applied to at least a part of a substrate.
本実施形態において、遺伝子検査容器用部材は、主として遺伝子検査容器を製造するための部材であり、フィルムやシートの形状のものを好適に用いることができる。また、本実施形態の遺伝子検査容器用部材は、包装材や包装体として用いることもできる。 In this embodiment, the genetic testing container member is a member for mainly manufacturing the genetic testing container, and a film or sheet shape can be suitably used. The genetic testing container member of this embodiment can also be used as a packaging material or package.
本実施形態の遺伝子検査容器用部材の材料としては、ポリエチレンやポリプロピレンなどのポリオレフィン系樹脂などを好適に用いることができる。例えば、ポリエチレン、エチレンとα-オレフィンの共重合体、エチレンと酢酸ビニルの共重合体、エチレンとアクリル酸やメタクリル酸共重合体と金属イオンを用いたアイオノマー等を挙げることができる。また、ポリオレフィン、スチレン系エラストマー、ポリエステル系熱可塑性エラストマー、シリコーン系熱可塑性エラストマー、シリコーン樹脂等を用いることもできる。さらに、シリコーンゴム、軟質塩化ビニル樹脂、ポリブタジエン樹脂、エチレン-酢酸ビニル共重合体、塩素化ポリエチレン樹脂、ポリウレタン系熱可塑性エラストマー、ポリエステル系熱可塑性エラストマー、シリコーン系熱可塑性エラストマー、スチレン系エラストマー、例えば、SBS(スチレン・ブタジエン・スチレン)、SIS(スチレン・イソプレン・スチレン)、SEBS(スチレン・エチレン・ブチレン・スチレン)、SEPS(スチレン・エチレン・プロピレン・スチレン)、ポリオレフィン樹脂、フッ素系樹脂等を用いてもよい。 As the material for the genetic testing container member of this embodiment, polyolefin resins such as polyethylene and polypropylene can be suitably used. For example, polyethylene, copolymers of ethylene and α-olefin, copolymers of ethylene and vinyl acetate, ionomers using ethylene, acrylic acid or methacrylic acid copolymers, and metal ions can be mentioned. In addition, polyolefins, styrene-based elastomers, polyester-based thermoplastic elastomers, silicone-based thermoplastic elastomers, silicone resins, etc. can also be used. Furthermore, silicone rubber, soft vinyl chloride resins, polybutadiene resins, ethylene-vinyl acetate copolymers, chlorinated polyethylene resins, polyurethane-based thermoplastic elastomers, polyester-based thermoplastic elastomers, silicone-based thermoplastic elastomers, styrene-based elastomers, such as SBS (styrene-butadiene-styrene), SIS (styrene-isoprene-styrene), SEBS (styrene-ethylene-butylene-styrene), SEPS (styrene-ethylene-propylene-styrene), polyolefin resins, fluorine-based resins, etc. may also be used.
本実施形態の遺伝子検査容器用部材において、遺伝子増幅用試薬には、少なくとも核酸合成酵素が含まれる。
このように、核酸合成酵素を含む遺伝子増幅用試薬を樹脂組成物と混合して基板上に塗布し、得られた遺伝子検査容器用部材を用いて形成され当該混合物が内部(当該容器内)に固定されたチューブを用いてPCRを行うことにより、ユーザは、PCR用反応液の調製工程において、酵素を調製するための1回の調製を省略することが可能になる。
核酸合成酵素としては、DNAを増幅可能なDNA polymeraseやRNAを増幅可能なRNA polymeraseを用いることができ、例えばTakara ExTaqなどを好適に用いることができる。
In the genetic testing container member of this embodiment, the gene amplification reagent contains at least a nucleic acid synthesizing enzyme.
In this way, a gene amplification reagent containing a nucleic acid synthesis enzyme is mixed with a resin composition and applied onto a substrate, and then PCR is performed using a tube formed using the resulting genetic testing container component and with the mixture fixed inside (inside the container).This enables the user to omit one preparation step for preparing the enzyme in the process of preparing the PCR reaction solution.
As the nucleic acid synthesizing enzyme, a DNA polymerase capable of amplifying DNA or an RNA polymerase capable of amplifying RNA can be used, and for example, Takara ExTaq or the like can be suitably used.
また、遺伝子増幅用試薬は、核酸合成酵素と共に、核酸合成基質と、プライマーと、緩衝液とからなる群より選択される少なくともいずれかを含むものとすることが好ましい。
すなわち、遺伝子増幅用試薬に2種類の試薬を含めることにより、ユーザは、PCR用反応液の調製工程において、調製を2回省略することができる。また、遺伝子増幅用試薬に3種類の試薬を含めることによって、調製を3回省略することができ、4種類の試薬を含めることによって、調製を4回省略することが可能である。
The gene amplification reagent preferably contains at least one selected from the group consisting of a nucleic acid synthesis substrate, a primer, and a buffer solution, together with the nucleic acid synthesis enzyme.
That is, by including two types of reagents in the gene amplification reagent, the user can omit two preparations in the PCR reaction solution preparation process, by including three types of reagents in the gene amplification reagent, the user can omit three preparations, and by including four types of reagents in the gene amplification reagent, the user can omit four preparations.
核酸合成基質としては、例えばDNAを対象とする場合には、dCTP、dATP、dTTP、及びdGTPの4種類のデオキシモノヌクレオチドリン酸を用いることができ、RNAを対象とする場合には、dCTP、dATP、dUTP、及びdGTPの4種類のデオキシモノヌクレオチドリン酸等を用いることができる。
プライマーとしては、検査対象の核酸を増幅するためのフォワードプライマー及びリバースプライマーからなる一又は複数のプライマーセットを用いることができる。また、緩衝液は、一般に使用されているものを用いることができる。
As nucleic acid synthesis substrates, for example, when DNA is the target, four types of deoxymononucleotide phosphates, dCTP, dATP, dTTP, and dGTP, can be used, and when RNA is the target, four types of deoxymononucleotide phosphates, dCTP, dATP, dUTP, and dGTP, can be used.
As the primers, one or more primer sets consisting of a forward primer and a reverse primer for amplifying the nucleic acid to be tested can be used. In addition, as the buffer solution, a commonly used one can be used.
また、本実施形態の遺伝子検査容器用部材は、樹脂組成物が感光性樹脂組成物であることが好ましく、混合物の表面が紫外線(UV)照射により硬化されてなるものとすることが好ましい。
このように遺伝子増幅用試薬と樹脂組成物との混合物の表面を硬化させることで、混合物内に格納された核酸合成酵素などを、PCRにおいて安定的に使用することが可能となる。
In addition, in the genetic testing container member of this embodiment, the resin composition is preferably a photosensitive resin composition, and the surface of the mixture is preferably cured by irradiation with ultraviolet (UV) rays.
By hardening the surface of the mixture of the gene amplification reagent and the resin composition in this manner, it becomes possible to stably use the nucleic acid synthesizing enzyme and the like contained in the mixture in PCR.
感光性樹脂組成物としては、感光性樹脂と重合開始剤を含有するものを用いることが好ましい。感光性樹脂としては、光架橋型や光重合型の感光性樹脂が使用され、具体的にはポリビニルアルコール/スチルバゾリウム系感光性樹脂、ポリビニルアルコール/酢酸ビニルの共重合物とアセタール化合物系感光性樹脂、ケイ皮酸あるいはカルコン等の光架橋型感光性樹脂、光架橋剤(例えば、ビスアジド化合物、ジアゾニウム塩等)あるいはビニルポリマーの共重合体との組み合わせ等からなる感光性樹脂、あるいはアクリル酸基を末端に有する光重合型の感光性樹脂からなる群より選択される少なくともいずれかを用いることが好ましい。また、重合開始剤としては、光重合開始剤や光ラジカル発生剤、光酸発生材、光塩基発生剤等を好適に用いることができる。 As the photosensitive resin composition, it is preferable to use one containing a photosensitive resin and a polymerization initiator. As the photosensitive resin, a photocrosslinking type or photopolymerization type photosensitive resin is used, and specifically, it is preferable to use at least one selected from the group consisting of polyvinyl alcohol/stilbazolium-based photosensitive resin, polyvinyl alcohol/vinyl acetate copolymer and acetal compound-based photosensitive resin, photocrosslinking type photosensitive resin such as cinnamic acid or chalcone, photocrosslinking agent (e.g., bisazide compound, diazonium salt, etc.) or a combination with a vinyl polymer copolymer, or photopolymerization type photosensitive resin having an acrylic acid group at the end. In addition, as the polymerization initiator, a photopolymerization initiator, a photoradical generator, a photoacid generator, a photobase generator, etc. can be suitably used.
本発明の遺伝子検査容器は、遺伝子検査容器用部材を用いて形成され、混合物が容器内に固定されたことを特徴としている。
また、本実施形態において、遺伝子検査容器を、先に容器を製造した後、容器内に遺伝子増幅用試薬と樹脂組成物とを注入して混合物を作成することによって、得ることもできる。この場合、遺伝子検査容器内の混合物に対して紫外線照射を行うことにより、混合物の表面が硬化されて容器内に固定された遺伝子検査容器を得ることができる。
The genetic testing container of the present invention is characterized in that it is formed using a member for a genetic testing container and a mixture is fixed inside the container.
In this embodiment, the genetic testing container can also be obtained by first manufacturing the container, and then injecting the gene amplification reagent and the resin composition into the container to create a mixture. In this case, the mixture in the genetic testing container can be irradiated with ultraviolet light to harden the surface of the mixture, thereby obtaining a genetic testing container fixed in the container.
本実施形態の遺伝子検査容器用部材は、例えば次のように作製することができる。
まず、核酸合成酵素、核酸合成基質、プライマー溶液、緩衝液、及び感光性樹脂組成物を、使い捨てチップなどを挿着させたピペットマンやマイクロピペットを用いて混合し、得られた混合物を用いて基板上に塗布する。この基板としては、前述した遺伝子検査容器用部材の材料と同様のものを用いることができる。
The member for a genetic testing container of this embodiment can be produced, for example, as follows.
First, the nucleic acid synthesis enzyme, the nucleic acid synthesis substrate, the primer solution, the buffer solution, and the photosensitive resin composition are mixed using a pipette or a micropipette with a disposable tip or the like attached, and the mixture obtained is applied onto a substrate. The substrate may be made of the same material as that of the above-mentioned genetic testing container member.
次に、混合物を塗布した基板を常温常圧下で一定時間(例えば1時間静置して)乾燥させ、次いで混合物に対して紫外線照射を行うことが好ましい。紫外線照射は、例えば25℃で2分間行うことが好ましい。
これにより、塗布された混合物の表面が紫外線照射により硬化された遺伝子検査容器用部材を得ることができる。
Next, the substrate on which the mixture has been applied is preferably dried for a certain period of time (e.g., one hour) at room temperature and normal pressure, and then the mixture is irradiated with ultraviolet light. The ultraviolet light irradiation is preferably performed for two minutes at 25°C, for example.
In this way, a member for a genetic testing container can be obtained in which the surface of the applied mixture is hardened by ultraviolet irradiation.
また、得られた遺伝子検査容器用部材を、ブロー成形、真空成形、又は圧空成形等で成形することにより、混合物が容器内に固定された遺伝子検査容器を得ることができる。
なお、前述のとおり、先に容器を製造した後、容器内に遺伝子増幅用試薬と樹脂組成物とを注入して混合物を作成し、容器を前述のように一定時間乾燥させた後、混合物に対して紫外線照射を行うことによって、遺伝子検査容器を得ることも可能である。
Furthermore, by molding the obtained member for a genetic testing vessel by blow molding, vacuum molding, pressure molding or the like, a genetic testing vessel in which the mixture is fixed inside the vessel can be obtained.
As described above, it is also possible to obtain a genetic testing container by first manufacturing the container, then injecting a gene amplification reagent and a resin composition into the container to create a mixture, drying the container for a certain period of time as described above, and then irradiating the mixture with ultraviolet light.
次に、このようにして得られた遺伝子検査容器を用いてPCRを行う場合に、遺伝子増幅用試薬がどのようにして働くのかについて説明する。
PCRは、例えば以下のような反応条件で行うことによって、ゲノムDNAにおける標的領域を好適に増幅させることができる。
(a)94℃ 10分、(b)98℃(DNA変性工程) 10秒、(c)60℃(アニーリング工程) 30秒、(d)72℃(DNA合成工程) 1分((b)~(d)を40サイクル)、(e)72℃ 10分
Next, how the gene amplification reagent works when PCR is carried out using the gene testing container thus obtained will be described.
PCR can suitably amplify a target region in genomic DNA, for example, by performing the PCR under the following reaction conditions.
(a) 94°C for 10 minutes, (b) 98°C (DNA denaturation step) for 10 seconds, (c) 60°C (annealing step) for 30 seconds, (d) 72°C (DNA synthesis step) for 1 minute (40 cycles of (b) to (d)), (e) 72°C for 10 minutes.
すなわち、遺伝子検査容器は、PCRの反応工程において、90℃以上の高温にさらされるため、容器内に固定された混合物の樹脂組成物が溶解し、混合物内に格納されていた遺伝子増幅用試薬が遺伝子検査容器内に遊離する。
これにより、以降は、PCR用反応液の一般的な調製方法を行った場合と同様に、対象核酸の増幅が行われて、増幅産物が生成する。
In other words, the genetic testing container is exposed to high temperatures of 90°C or higher during the PCR reaction process, causing the resin composition of the mixture fixed within the container to dissolve and the gene amplification reagents contained within the mixture to become liberated into the genetic testing container.
Thereafter, the target nucleic acid is amplified to produce an amplified product in the same manner as in the case of carrying out a general method for preparing a reaction solution for PCR.
以上説明したとおり、本実施形態によれば、遺伝子増幅用試薬と樹脂組成物とが混合され、その表面が硬化された混合物が固定された遺伝子検査容器を得ることができる。
このような遺伝子検査容器を用いることにより、特別な機器や施設を必要とすることなく、核酸を増幅するための反応液の調製工程を簡略化することが可能である。
As described above, according to this embodiment, a gene amplification reagent and a resin composition are mixed, and a genetic testing container having a hardened mixture fixed on the surface can be obtained.
By using such a genetic testing container, it is possible to simplify the process of preparing a reaction solution for amplifying nucleic acid without requiring special equipment or facilities.
以下、本発明の実施形態に係る遺伝子検査容器を用いて行った試験について説明する。
具体的には、遺伝子検査用試薬と感光性樹脂の混合物が紫外線照射により硬化して内部に固定されたチューブを用いてPCRを行い、増幅産物が得られたか否かの検証を行った。
Tests carried out using the genetic testing container according to the embodiment of the present invention will be described below.
Specifically, PCR was performed using a tube in which a mixture of a genetic testing reagent and a photosensitive resin was hardened by exposure to ultraviolet light and fixed inside, and it was verified whether an amplified product was obtained.
対象菌としては、次の菌株を使用した。
Listeria monocytogenes ATCC 15313
The following strains were used as control bacteria:
Listeria monocytogenes ATCC 15313
この菌株の増菌培養を、Brain HeartInfusion(Difco社製)を用いて、37℃で、1~2日間静置させて行った。
次に、得られた増菌培地から、RBC Genomic DNA Extraction Kit Mini(RBC Bioscience社製)を用いて、その説明書に従いゲノムDNAを抽出した。
This strain was cultured in a Brain Heart Infusion (Difco) at 37° C. for 1 to 2 days.
Next, genomic DNA was extracted from the obtained enrichment medium using RBC Genomic DNA Extraction Kit Mini (RBC Bioscience) according to the manufacturer's instructions.
サンプルとして、以下の表に示す4種類のものを準備した。
サンプル1は、PCR用反応液の一般的な調製方法によるものであり、酵素、プライマー、基質、及び緩衝液を、調製時に添加した。
サンプル2は、遺伝子検査用試薬の酵素のみと感光性樹脂との混合物を固定した遺伝子検査容器を用いて、酵素の調製のみを省略可能にしたものである。
Sample 1 was prepared by a general method for preparing a reaction solution for PCR, and the enzyme, primer, substrate, and buffer solution were added during preparation.
Sample 2 uses a genetic testing container in which a mixture of only the enzyme of the genetic testing reagent and a photosensitive resin is immobilized, making it possible to omit the preparation of the enzyme alone.
サンプル3は、遺伝子検査用試薬の酵素、プライマー、基質、及び緩衝液と感光性樹脂との混合物を固定した遺伝子検査容器を用いて、これら4種類の遺伝子検査用試薬の調製を省略可能にしたものである。
サンプルNは、ネガティブであり、サンプル3と同じ遺伝子検査容器を用いて、対象核酸を添加しなかったものである。
Sample 3 uses a genetic testing container in which the enzymes, primers, substrates, and a mixture of buffer solution and photosensitive resin of the genetic testing reagents are fixed, making it possible to omit the preparation of these four types of genetic testing reagents.
Sample N was a negative sample, and was prepared using the same genetic testing container as sample 3, but without adding the target nucleic acid.
具体的には、サンプル2の遺伝子検査容器は、次のように作製した。
感光性樹脂(BIOSURFINE-AWP-MRH、東洋合成工業株式会社製)0.25μLとTakara Ex Taq HS 0.25μLを0.2mL用PCRチューブ内で混合した。チューブを閉めた状態で、37℃で1時間保管後、感光性樹脂の硬化のためにチューブを開けた状態で、UV灯(感光基板用ライトボックス、サンハヤト社製)を用いて、25℃で2分間チューブ内を照射して、サンプル2の遺伝子検査容器を得た。
Specifically, the genetic testing container of Sample 2 was prepared as follows.
0.25 μL of photosensitive resin (BIOSURFINE-AWP-MRH, manufactured by Toyo Gosei Co., Ltd.) and 0.25 μL of Takara Ex Taq HS were mixed in a 0.2 mL PCR tube. After storing the tube in a closed state at 37° C. for 1 hour, the tube was opened to harden the photosensitive resin, and the inside of the tube was irradiated with a UV lamp (light box for photosensitive substrates, manufactured by Sanhayato Co., Ltd.) at 25° C. for 2 minutes to obtain a genetic testing container for sample 2.
サンプル3の遺伝子検査容器は、次のように作製した。
感光性樹脂(BIOSURFINE-AWP-MRH、東洋合成工業株式会社製)11.25μL、Takara Ex Taq HS 0.25 μL、10×EX Taq Buffer5.0μL、dNTP mixer 4.0μL、及びプライマー溶液各1.0μLを0.2mL用PCRチューブ内で混合した。チューブを閉めた状態で、37℃で1時間保管後、感光性樹脂の硬化のためにチューブを開けた状態で、UV灯(感光基板用ライトボックス、サンハヤト社製)を用いて、25℃で2分間チューブ内を照射して、サンプル3の遺伝子検査容器を得た。
The genetic testing container of Sample 3 was prepared as follows.
11.25 μL of photosensitive resin (BIOSURFINE-AWP-MRH, manufactured by Toyo Gosei Co., Ltd.), 0.25 μL of Takara Ex Taq HS, 5.0 μL of 10×EX Taq Buffer, 4.0 μL of dNTP mixer, and 1.0 μL of each primer solution were mixed in a 0.2 mL PCR tube. After storing the tube at 37°C for 1 hour with the tube closed, the tube was opened to harden the photosensitive resin, and the inside of the tube was irradiated with a UV lamp (light box for photosensitive substrates, manufactured by Sanhayato Co., Ltd.) at 25°C for 2 minutes to obtain a genetic testing container for sample 3.
PCR用反応液は、一律に、リステリア属菌のDNAを増幅させるための配列番号1に示す塩基配列からなるフォワードプライマーと配列番号2に示す塩基配列からなるリバースプライマーとからなるプライマーセットが含まれるものを使用した。これらのプライマーは、シグマ アルドリッチ ジャパン合同会社により合成した。 The PCR reaction solution used contained a primer set consisting of a forward primer with the base sequence shown in SEQ ID NO:1 and a reverse primer with the base sequence shown in SEQ ID NO:2 for amplifying the DNA of Listeria. These primers were synthesized by Sigma-Aldrich Japan LLC.
サンプル1用のPCR用反応液としては、次の組成のものを50μl作成した。
1.10×Ex Taq buffer(Mg2+ plus) (20 mM) (タカラバイオ社製) 5.0μl
2.dNTP mixer 2.5mM each (タカラバイオ社製) 4.0μl
3.10μMフォワードプライマー(配列番号1) 1.0μl
4.10μMリバースプライマー(配列番号2) 1.0μl
5.Takara Ex Taq HS(5U/μl) (タカラバイオ社製) 0.25μl
6. Template DNA(1ng/PCR用反応液) 2.0μl
7.滅菌水(全体が50.0μlになるまで加水)
As a PCR reaction solution for sample 1, 50 μl of the following composition was prepared.
1. 10xEx Taq buffer (Mg2+ plus) (20 mM) (Takara Bio) 5.0 μl
2. dNTP mixer 2.5mM each (Takara Bio) 4.0μl
3. 10 μM forward primer (SEQ ID NO: 1) 1.0 μl
4. 10 μM reverse primer (SEQ ID NO: 2) 1.0 μl
5. Takara Ex Taq HS (5U/μl) (Takara Bio) 0.25μl
6. Template DNA (1 ng/PCR reaction solution) 2.0 μl
7. Sterile water (add water until the total volume is 50.0 μl)
サンプル2用のPCR用反応液としては、次の組成のものと事前にチューブ内に硬化させたTakara Ex Taq HS 0.25μlを含めて全量で50μl(感光性樹脂の量は含まず)作成した。
1.10×Ex Taq buffer(Mg2+ plus) (20 mM) (タカラバイオ社製) 5.0μl
2.dNTP mixer 2.5mM each (タカラバイオ社製) 4.0μl
3.10μMフォワードプライマー(配列番号1) 1.0μl
4.10μMリバースプライマー(配列番号2) 1.0μl
5. Template DNA(1ng/PCR用反応液) 2.0μl
6.滅菌水(全体が50.0μlになるまで加水)
The PCR reaction solution for sample 2 was prepared in a total volume of 50 μl (excluding the amount of photosensitive resin) containing the following composition and 0.25 μl of Takara Ex Taq HS that had been hardened in advance in a tube.
1. 10xEx Taq buffer (Mg2+ plus) (20 mM) (Takara Bio) 5.0 μl
2. dNTP mixer 2.5mM each (Takara Bio) 4.0μl
3. 10 μM forward primer (SEQ ID NO: 1) 1.0 μl
4. 10 μM reverse primer (SEQ ID NO: 2) 1.0 μl
5. Template DNA (1 ng/PCR reaction solution) 2.0 μl
6. Sterile water (add water until the total volume is 50.0 μl)
サンプル3のPCR用反応液としては、次の組成のものと事前にチューブ内に硬化させたTakara Ex Taq HS 0.25μL、10×Ex Taq buffer(Mg2+ plus) 5.0μl、dNTP mixer 4.0μl、プライマー溶液各1.0μlを含めて全量で50μl(感光性樹脂の量は含まず)作成した。
1.Template DNA(1ng/PCR用反応液) 2.0μl
2.滅菌水(全体が50.0μlになるまで加水)
サンプルN用のPCR用反応液は、滅菌水(50.0μl)とした。
The PCR reaction solution for sample 3 was prepared in a total volume of 50 μl (excluding the amount of photosensitive resin) containing the following composition: 0.25 μl of Takara Ex Taq HS that had been hardened in advance in a tube, 5.0 μl of 10x Ex Taq buffer (Mg2+ plus), 4.0 μl of dNTP mixer, and 1.0 μl each of primer solution.
1. Template DNA (1 ng/PCR reaction solution) 2.0 μl
2. Sterile water (add water until the total volume is 50.0 μl)
The PCR reaction solution for sample N was sterile water (50.0 μl).
上記各PCR用反応液を使用して、核酸増幅装置(Master cycler ep、Eppendorf社)を用いて、次の条件でDNAの増幅を行った。
(a)94℃ 10分
(b)98℃ 10秒
(c)60℃ 30秒
(d)72℃ 1分((b)~(d)を40サイクル)
(e)72℃ 10分
Using each of the above PCR reaction solutions, DNA amplification was carried out using a nucleic acid amplifier (Master cycler ep, Eppendorf) under the following conditions.
(a) 94°C 10 min (b) 98°C 10 sec (c) 60°C 30 sec (d) 72°C 1 min (40 cycles of (b) to (d))
(e) 72°C 10 minutes
PCR法による増幅産物の電気泳動を、電気泳動装置(MultiNA、株式会社島津製作所製)を用いて行った。上記プライマーを用いる場合の増幅産物長が163bpであるため、163bp付近に増幅産物が存在すれば、陽性と判定した。その結果を図1に示す。 Electrophoresis of the PCR amplified products was performed using an electrophoresis device (MultiNA, Shimadzu Corporation). Since the length of the amplified product when using the above primers was 163 bp, the presence of an amplified product near 163 bp was judged to be positive. The results are shown in Figure 1.
図1に示されるように、サンプル2,3の遺伝子検査容器を用いた場合、サンプル1と同様に、対象核酸の増幅産物が得られていた。
このように、上記実施形態の遺伝子検査容器を用いた場合、特別な機器や施設を用いることなく、反応液の調製工程を簡略化して、PCRを好適に行うことができることが確認された。
As shown in FIG. 1, when the genetic testing containers of Samples 2 and 3 were used, an amplification product of the target nucleic acid was obtained, similarly to Sample 1.
In this way, it was confirmed that when the genetic testing container of the above embodiment is used, the reaction solution preparation process can be simplified and PCR can be performed suitably without using special equipment or facilities.
本発明は、以上の実施形態や実施例に限定されるものではなく、本発明の範囲内において、種々の変更実施が可能であることは言うまでもない。
例えば、遺伝子検査用試薬として、上記で用いたもの以外の他の試薬を含めて用いる場合等に、それらを含めた混合物を作成するなど、適宜変更することが可能である。
The present invention is not limited to the above-described embodiments and examples, and it goes without saying that various modifications and variations are possible within the scope of the present invention.
For example, when other reagents than those used above are used as the genetic testing reagent, appropriate modifications can be made, such as preparing a mixture including those reagents.
本発明は、環境検査、食品検査等において、細菌などの微生物等を特異的に検出する場合に好適に利用することが可能である。 The present invention can be suitably used to specifically detect microorganisms such as bacteria in environmental testing, food testing, etc.
Claims (4)
前記遺伝子増幅用試薬が、核酸合成酵素と緩衝液と核酸合成基質とプライマーを含み、
前記核酸合成基質が、dCTP、dATP、dTTP、及びdGTPの4種類のデオキシモノヌクレオチドリン酸、又は、dCTP、dATP、dUTP、及びdGTPの4種類のデオキシモノヌクレオチドリン酸からなることを特徴とする遺伝子検査容器用部材。 A mixture containing one or more gene amplification reagents containing at least a nucleic acid synthesizing enzyme and a resin composition is applied to at least a part of a substrate,
the gene amplification reagent comprises a nucleic acid synthesis enzyme, a buffer solution, a nucleic acid synthesis substrate, and a primer;
A member for a genetic testing container, characterized in that the nucleic acid synthesis substrate comprises four kinds of deoxymononucleotide phosphates, dCTP, dATP, dTTP, and dGTP, or four kinds of deoxymononucleotide phosphates, dCTP, dATP, dUTP, and dGTP.
4. A genetic testing vessel, comprising the member for a genetic testing vessel according to claim 1, and the mixture is fixed in the vessel.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019187669A JP7486015B2 (en) | 2019-10-11 | 2019-10-11 | Component for genetic testing container, and genetic testing container |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019187669A JP7486015B2 (en) | 2019-10-11 | 2019-10-11 | Component for genetic testing container, and genetic testing container |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021061771A JP2021061771A (en) | 2021-04-22 |
| JP7486015B2 true JP7486015B2 (en) | 2024-05-17 |
Family
ID=75486062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019187669A Active JP7486015B2 (en) | 2019-10-11 | 2019-10-11 | Component for genetic testing container, and genetic testing container |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP7486015B2 (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050112634A1 (en) | 2003-09-19 | 2005-05-26 | Woudenberg Timothy M. | High density sequence detection methods and apparatus |
| JP2008268197A (en) | 2007-03-29 | 2008-11-06 | Cci Corp | Protein-immobilized membrane, protein immobilization method, and biosensor |
| WO2010026950A1 (en) | 2008-09-08 | 2010-03-11 | 株式会社日立製作所 | Dna detection apparatus, dna detection device and dna detection method |
| JP2013066463A (en) | 2011-09-08 | 2013-04-18 | Toshiba Corp | Multi-nucleic acid reaction tool and detection method using same |
| JP2016010402A (en) | 2014-06-03 | 2016-01-21 | 国立研究開発法人産業技術総合研究所 | Amplification method for ultralow volume of nucleic acid |
-
2019
- 2019-10-11 JP JP2019187669A patent/JP7486015B2/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050112634A1 (en) | 2003-09-19 | 2005-05-26 | Woudenberg Timothy M. | High density sequence detection methods and apparatus |
| JP2008268197A (en) | 2007-03-29 | 2008-11-06 | Cci Corp | Protein-immobilized membrane, protein immobilization method, and biosensor |
| WO2010026950A1 (en) | 2008-09-08 | 2010-03-11 | 株式会社日立製作所 | Dna detection apparatus, dna detection device and dna detection method |
| JP2013066463A (en) | 2011-09-08 | 2013-04-18 | Toshiba Corp | Multi-nucleic acid reaction tool and detection method using same |
| JP2016010402A (en) | 2014-06-03 | 2016-01-21 | 国立研究開発法人産業技術総合研究所 | Amplification method for ultralow volume of nucleic acid |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2021061771A (en) | 2021-04-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7610774B2 (en) | Devices, processes and systems for determining nucleic acid sequence, expression, copy number or methylation changes using a combination of nuclease, ligase, polymerase and sequencing reactions - Patents.com | |
| US9139871B2 (en) | Methods and apparatuses | |
| CA2365135C (en) | Method for amplifying nucleic acid sequence | |
| EP3132048A1 (en) | Method for synthesising nucleic acids, in particular long nucleic acids, use of said method and kit for implementing said method | |
| CN102296023A (en) | Microchip for isothermal nucleic-acid amplification reaction, method for producing the same, and isothermal nucleic-acid amplification method | |
| JP2011160728A (en) | Microchip for nucleic acid amplification reaction and manufacturing method thereof | |
| JP7486015B2 (en) | Component for genetic testing container, and genetic testing container | |
| US20200318160A1 (en) | Sample to Sequence | |
| JP3927580B2 (en) | DNA chain extension method, DNA chain amplification method, and DNA array extension microarray | |
| KR20210101596A (en) | Reaction chip for PCR comprising multiple hydrogel microparticles arranged on a hydrophobic plate | |
| CN104160011A (en) | Method for producing microchip for use in nucleic acid amplification reaction | |
| US20100081175A1 (en) | Enzyme-containing gels and nucleic acid amplifying kits | |
| JP2009219358A (en) | Method for detecting gene and carrier for detecting gene | |
| CN110312787B (en) | Cell culture method and cell culture system | |
| JP2007222010A (en) | Method for detecting gene and carrier for detecting gene | |
| US20100081176A1 (en) | Enzyme-containing capsules and nucleic acid amplification kits | |
| JP2005130795A (en) | Polynucleotide analysis member and method for determining the presence or absence of a polynucleotide having a specific base sequence in a specimen | |
| KR102088877B1 (en) | Particle using ucst and method for amplifying nucleic acid using same | |
| WO2024069938A1 (en) | Reaction vessel for nucleic acid amplification, cartridge, and nucleic acid detection method | |
| JP2005192555A (en) | Reactor for enzyme reaction and method for producing the same | |
| JP2007289088A (en) | Gene detection method | |
| JP2023026236A (en) | Reaction vessel and cartridge for nucleic acid amplification, and nucleic acid detection method | |
| WO1999058725A1 (en) | Process for obtaining amplified fragments of nucleic acid of viral and sub-viral particles which contain rna | |
| JP2005168350A (en) | Method for determining the presence or absence of a single nucleotide polymorphism or mutation of a polynucleotide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220909 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20230720 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230801 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230930 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20231219 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240306 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20240311 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20240403 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20240416 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7486015 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |